• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 29-07-2026: Press Release

    29-07-2026 | 09:59 pm

    Sun Pharma secured approval to manufacture & market semaglutide injection in Brazil for type 2 diabetes. Launch with Hypera Pharma is imminent in the ~USD 41.3 Cr Brazilian market, strengthening its diabetes portfolio.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited